Glenmede Trust’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-176
Closed -$15K 2221
2020
Q3
$15K Buy
176
+8
+5% +$688 ﹤0.01% 1719
2020
Q2
$13K Buy
168
+77
+85% +$5.62K ﹤0.01% 1778
2020
Q1
$10K Hold
91
﹤0.01% 2437
2019
Q4
$10K Buy
91
+38
+72% +$4.73K ﹤0.01% 2437
2019
Q3
$6 Buy
53
+16
+43% +$2.08K ﹤0.01% 2581
2019
Q2
$4 Hold
37
﹤0.01% 2708
2019
Q1
$3 Sell
37
-55
-60% -$5.91K ﹤0.01% 2771
2018
Q4
$9 Buy
+92
New +$10.2K ﹤0.01% 2328
2018
Q2
Sell
-55
Closed -$3K 2315
2018
Q1
$3K Hold
55
﹤0.01% 2536
2017
Q4
$3K Hold
55
﹤0.01% 2536
2017
Q3
$3K Sell
55
-9,493
-99% -$578K ﹤0.01% 2502
2017
Q2
$622K Hold
9,548
﹤0.01% 886
2017
Q1
$622K Hold
9,548
﹤0.01% 886
2016
Q4
$669K Hold
9,548
﹤0.01% 852
2016
Q3
$598K Hold
9,548
﹤0.01% 874
2016
Q2
$574K Hold
9,548
﹤0.01% 879
2016
Q1
$474K Hold
9,548
﹤0.01% 934
2015
Q4
$511K Hold
9,548
﹤0.01% 907
2015
Q3
$428K Hold
9,548
﹤0.01% 964
2015
Q2
$522K Hold
9,548
﹤0.01% 929
2015
Q1
$452K Hold
9,548
﹤0.01% 991
2014
Q4
$400K Buy
9,548
+9,493
+17,260% +$374K ﹤0.01% 1045
2014
Q3
$1K Buy
+55
New +$1.94K ﹤0.01% 2408

Other funds holding USPH

Glenmede Trust's USPH Position: Q4 2020 in Review

Glenmede Trust sold out of US Physical Therapy (USPH) in Q4 2020, closing a stake of 176 shares — an estimated $15K sold.

Glenmede Trust first reported a position in USPH in Q3 2014 and held it in 23 quarters. The position peaked at $669K in Q4 2016. 204 funds tracked by Wall St. Rank hold USPH as of Q4 2020.

  • Glenmede Trust reported no remaining US Physical Therapy position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 176 US Physical Therapy shares in Q4 2020, an estimated $15K.
  • Glenmede Trust first reported a position in US Physical Therapy in Q3 2014 and held it in 23 quarters.
  • Glenmede Trust's US Physical Therapy position peaked at $669K in Q4 2016.
  • 204 funds tracked by Wall St. Rank held US Physical Therapy as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.